Related Experiment Videos
[Biological markers: utilization in drug development and approval]
F Gueyffier1, M Dib, J P Boissel
1Service de Pharmacologie Clinique, Faculté de Médecine RTH Laennec, Rue Guillaume Paradin, BP 8071, 69376 Lyon 08, France.
Therapie
|October 27, 2001
Summary
Biomarkers significantly enhance drug development by improving screening accuracy, speeding up processes, and personalizing treatment. Optimizing their use requires better data collection, modeling, and integrated research approaches for effective pharmacology.
Area of Science:
- Pharmacology and Drug Development
- Biomarker Discovery and Application
- Translational Medicine
Context:
- Biomarkers are crucial for modern drug development, extending beyond simple surrogacy.
- Current challenges exist in biomarker transfer, evaluation, and interdisciplinary validation.
- Pharmacogenetics offers potential for personalized medicine through individual drug response profiling.
Purpose:
- To highlight the multifaceted objectives of biomarker utilization in pharmacology.
- To underscore the role of biomarkers in enhancing drug screening, development timelines, and patient stratification.
- To explore the potential of pharmacogenetics in optimizing drug selection and monitoring.
Summary:
- Biomarkers improve drug candidate screening, accelerate development, identify patient responders, and optimize drug monitoring.
- Applications include diagnosis, prognosis, and prediction of therapeutic responses (both positive and adverse).
- Systematic data collection, formal process modeling, and integrated research approaches are key to achieving biomarker objectives.
Impact:
- Facilitates more efficient and accurate drug development pipelines.
- Enables personalized medicine by tailoring drug choices to individual patient profiles.
- Optimizes drug efficacy and safety through precise patient selection and monitoring.